Antibody Fab Fragment

Overview

BOT Bioscience’s Antibody Fab Fragments (Fragment, Antigen-Binding) are recombinant or enzyme-cleaved antibody fragments that retain only the antigen-binding domain—consisting of one light chain and the variable region + first constant region of one heavy chain—without the Fc (Fragment, Crystallizable) region. As a key functional fragment of antibodies, they bind exclusively to a single epitope of targets (e.g., cell surface receptors, viral antigens, soluble proteins) while eliminating Fc-mediated non-specific interactions (e.g., binding to Fc receptors on immune cells, complement activation).

 

Produced via two optimized methods—recombinant expression (cloning Fab-encoding genes into mammalian/yeast hosts for high-purity production) or enzyme cleavage (papain digestion of full-length antibodies followed by affinity purification)—each Fab Fragment undergoes strict validation: specificity testing via Western blot/ELISA (to confirm target binding and rule out cross-reactivity), binding affinity measurement via surface plasmon resonance (SPR), and purity verification (≥95% via SDS-PAGE). Supplied as a stable liquid formulation (in PBS with protease inhibitors), they are ideal for applications requiring minimal background and precise antigen recognition.

 

Applications

Biomedical Research: Enable interference-free target detection—e.g., using Fab Fragments for immunofluorescence (IF) imaging of intracellular proteins (avoiding Fc binding to cell surface Fc receptors), or for co-immunoprecipitation (Co-IP) of weak antigen-antibody complexes (reducing non-specific protein pull-down).

Diagnostic Assays: Serve as low-background detection reagents—such as in lateral flow tests for foodborne toxins (e.g., aflatoxin, ochratoxin) or sandwich ELISA for autoimmune disease biomarkers (e.g., anti-nuclear antibodies), where Fc-mediated cross-reactivity would disrupt results.

Functional Assays: Support receptor-ligand interaction studies—e.g., using Fab Fragments of anti-EGFR to block EGFR-ligand binding (without triggering Fc-dependent cell signaling), or Fab Fragments of viral antigen-specific antibodies to neutralize viral infection (avoiding complement-mediated cell lysis).

Industrial Quality Control: Ensure accuracy in bioproduct testing—e.g., using Fab Fragments to detect residual full-length antibodies in recombinant protein drugs (avoiding Fc-based cross-reactivity with host cell proteins), or to quantify antigen levels in vaccine formulations.

 

Advantages

Minimized Non-Specific Binding: Lack of Fc region eliminates interactions with Fc receptors (on macrophages, neutrophils) and complement proteins, drastically reducing background signal in complex samples (e.g., whole blood, tissue lysates).

Enhanced Tissue Penetration: Smaller molecular weight (~50 kDa, half the size of full-length IgG) enables deeper penetration into dense tissues (e.g., tumor sections, solid organs) for more uniform antigen detection vs. full-length antibodies.

Targeted Functional Activity: Retains full antigen-binding specificity while avoiding Fc-mediated biological effects (e.g., antibody-dependent cellular cytotoxicity, ADCC), making it ideal for functional blocking assays where Fc signaling would confound results.

Broad Compatibility: Pre-validated for common techniques (Western blot, IF, ELISA, flow cytometry) and compatible with label conjugation (HRP, FITC, biotin) for customized detection needs—seamlessly integrating into existing experimental workflows.

High Purity & Stability: Recombinant production ensures batch-to-batch consistency (no enzyme cleavage variability), while protease inhibitor-supplemented formulations maintain activity for long-term storage (≥6 months at -20°C).